FDA Settles Allegations Of Uneven Blood Treatment Standards
By Ruben Castaneda · February 8, 2024, 8:32 PM EST
The U.S. Food and Drug Administration has settled a pharmaceutical company's lawsuit in D.C. federal court accusing the agency of subjecting the company's blood-clotting medication to costly clinical trials and higher...
To view the full article, register now.